Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C J Harrison

Showing results (191-200 of 199) with videos related to

Pageof 20
Sort By:
You have reached the last page of results.This site can display upto 199 results.
Pediatric Blood & Cancer|December 2, 2016
A phase I/II trial of AT9283, a selective inhibitor of aurora kinase in children with relapsed or refractory acute leukemia: challenges to run early phase clinical trials for children with leukemiaB Vormoor, G J Veal, M J Griffin, et al.
Leukemia|May 12, 2016
The role of the RAS pathway in iAMP21-ALLS L Ryan, E Matheson, V Grossmann, et al.
Oncogene|December 23, 2014
c-MYC is a radiosensitive locus in human breast cellsM A Wade, N J Sunter, S E Fordham, et al.
Leukemia|October 17, 2008
Heterogeneous patterns of amplification of the NUP214-ABL1 fusion gene in T-cell acute lymphoblastic leukemiaC Graux, M Stevens-Kroef, M Lafage, et al.
Leukemia|March 24, 2012
Outcome in children with Down's syndrome and acute lymphoblastic leukemia: role of IKZF1 deletions and CRLF2 aberrationsT D Buitenkamp, R Pieters, N E Gallimore, et al.
Leukemia|March 27, 2004
Secondary cytogenetic aberrations in childhood Philadelphia chromosome positive acute lymphoblastic leukemia are nonrandom and may be associated with outcomeN A Heerema, J Harbott, S Galimberti, et al.
Leukemia|October 30, 2013
An international study of intrachromosomal amplification of chromosome 21 (iAMP21): cytogenetic characterization and outcomeC J Harrison, A V Moorman, C Schwab, et al.
Leukemia|April 12, 2003
Clinical heterogeneity in childhood acute lymphoblastic leukemia with 11q23 rearrangementsC-H Pui, J M Chessells, B Camitta, et al.
Leukemia|October 4, 2016
A genome-wide association study identifies risk loci for childhood acute lymphoblastic leukemia at 10q26.13 and 12q23.1J Vijayakrishnan, R Kumar, M Y R Henrion, et al.
Pageof 20

Showing results (191-200 of 199) with videos related to

Sort By:
Pageof 20
You have reached the last page of results.This site can display upto 199 results.
Pediatric Blood & Cancer|December 2, 2016
A phase I/II trial of AT9283, a selective inhibitor of aurora kinase in children with relapsed or refractory acute leukemia: challenges to run early phase clinical trials for children with leukemiaB Vormoor, G J Veal, M J Griffin, et al.
Leukemia|May 12, 2016
The role of the RAS pathway in iAMP21-ALLS L Ryan, E Matheson, V Grossmann, et al.
Oncogene|December 23, 2014
c-MYC is a radiosensitive locus in human breast cellsM A Wade, N J Sunter, S E Fordham, et al.
Leukemia|October 17, 2008
Heterogeneous patterns of amplification of the NUP214-ABL1 fusion gene in T-cell acute lymphoblastic leukemiaC Graux, M Stevens-Kroef, M Lafage, et al.
Leukemia|March 24, 2012
Outcome in children with Down's syndrome and acute lymphoblastic leukemia: role of IKZF1 deletions and CRLF2 aberrationsT D Buitenkamp, R Pieters, N E Gallimore, et al.
Leukemia|March 27, 2004
Secondary cytogenetic aberrations in childhood Philadelphia chromosome positive acute lymphoblastic leukemia are nonrandom and may be associated with outcomeN A Heerema, J Harbott, S Galimberti, et al.
Leukemia|October 30, 2013
An international study of intrachromosomal amplification of chromosome 21 (iAMP21): cytogenetic characterization and outcomeC J Harrison, A V Moorman, C Schwab, et al.
Leukemia|April 12, 2003
Clinical heterogeneity in childhood acute lymphoblastic leukemia with 11q23 rearrangementsC-H Pui, J M Chessells, B Camitta, et al.
Leukemia|October 4, 2016
A genome-wide association study identifies risk loci for childhood acute lymphoblastic leukemia at 10q26.13 and 12q23.1J Vijayakrishnan, R Kumar, M Y R Henrion, et al.
Pageof 20